Ocugen (OCGN) Shares Issued (2014 - 2026)
Ocugen posted quarterly Shares Issued of $15.0 million for Q1 2026, up 6222.45% year-on-year from $237249.8 in Q1 2025, and up 881.68% on a QoQ basis from $1.5 million in Q4 2025.
Ocugen (OCGN) has 13 years of Shares Issued data on file, last reported at $15.0 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Issued rose 6222.45% year-over-year to $15.0 million; the trailing twelve-month figure through Mar 2026 stood at $17.3 million (up 2744.15% YoY), and the FY2025 full-year result was $19.9 million, down 48.51% from the prior year.
- Shares Issued for Q1 2026 stood at $15.0 million, up from $1.5 million in the prior quarter.
- Across five years, Shares Issued topped out at $50.2 million in Q1 2022 and bottomed at -$245000.0 in Q1 2025.
- The 5-year median for Shares Issued is $981000.0 (2024), against an average of $7.5 million.
- The widest annual swing landed in 2024, when Shares Issued plunged 102.53%; it then surged 6222.45% in 2026.
- A 5-year view of Shares Issued shows it stood at $8.4 million in 2022, then sank by 99.81% to $16000.0 in 2023, then jumped by 6031.25% to $981000.0 in 2024, then jumped by 55.76% to $1.5 million in 2025, then jumped by 881.68% to $15.0 million in 2026.
- The last three Shares Issued figures came in at $15.0 million (Q1 2026), $1.5 million (Q4 2025), and -$245000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - | 15.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.00 Mn |
| Mar 31, 2026 | 15.00 Mn |
| Dec 31, 2025 | 1.53 Mn |
| Dec 31, 2025 | 1.53 Mn |
| Mar 31, 2025 | -245,000.00 |
| Mar 31, 2025 | -245,000.00 |
| Dec 31, 2024 | 981,000.00 |
| Dec 31, 2024 | 981,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | 98,000.00 |
| Sep 30, 2023 | 98,000.00 |
| Jun 30, 2023 | 14.96 Mn |
| Jun 30, 2023 | 14.96 Mn |
| Mar 31, 2023 | 5.73 Mn |
| Mar 31, 2023 | 5.73 Mn |
| Dec 31, 2022 | 8.43 Mn |
| Dec 31, 2022 | 8.43 Mn |
| Sep 30, 2022 | 603,000.00 |
| Sep 30, 2022 | 603,000.00 |
| Jun 30, 2022 | 361,000.00 |
| Jun 30, 2022 | 361,000.00 |
| Mar 31, 2022 | 50.18 Mn |
| Mar 31, 2022 | 50.18 Mn |
| Dec 31, 2021 | 605,000.00 |
| Dec 31, 2021 | 605,000.00 |
| Sep 30, 2021 | 128.00 Mn |
| Sep 30, 2021 | 128.00 Mn |
| Jun 30, 2021 | -27.52 Mn |
| Jun 30, 2021 | -27.52 Mn |
| Mar 31, 2021 | 28.13 Mn |
| Mar 31, 2021 | 28.13 Mn |
| Dec 31, 2020 | 37.82 Mn |
| Dec 31, 2020 | 37.82 Mn |
| Dec 31, 2019 | -999,832.00 |
| Dec 31, 2019 | -999,832.00 |
| Sep 30, 2019 | -168.00 |
| Sep 30, 2019 | -168.00 |
| Jun 30, 2019 | 800,000.00 |
| Jun 30, 2019 | 800,000.00 |
| Mar 31, 2019 | 200,000.00 |
| Mar 31, 2019 | 200,000.00 |
| Dec 31, 2018 | -2,000.00 |
| Dec 31, 2018 | -2,000.00 |
| Mar 31, 2018 | 2,000.00 |
| Mar 31, 2018 | 2,000.00 |
| Dec 31, 2017 | 1,000.00 |
| Dec 31, 2017 | 1,000.00 |
| Mar 31, 2016 | 1,000.00 |
| Mar 31, 2016 | 1,000.00 |
| Dec 31, 2015 | 4.70 Mn |
| Dec 31, 2015 | 4.70 Mn |
| Sep 30, 2015 | 27,000.00 |
| Sep 30, 2015 | 27,000.00 |
| Jun 30, 2015 | -4.73 Mn |
| Jun 30, 2015 | -4.73 Mn |
| Mar 31, 2015 | 4.74 Mn |
| Mar 31, 2015 | 4.74 Mn |
| Dec 31, 2014 | 60.42 Mn |
| Dec 31, 2014 | 60.42 Mn |
| Sep 30, 2014 | 1,000.00 |
| Sep 30, 2014 | 1,000.00 |